SCHEMBL15417599

SCHEMBL15417599

Nc1nc(-c2cccc(CF)c2F)cs1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPL P40238 5/20 0.60
HSD17B10 Q99714 5/20 0.49
MAPT P10636 5/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
KDM4E B2RXH2 3/20 0.46
RAB9A P51151 5/20 0.46
GAA P10253 1/20 0.46
ALDH1A1 P00352 6/20 0.44
ALOX5 P09917 1/20 0.44
TYR P14679 1/20 0.41
LTA4H P09960 2/20 0.40
NPC1 O15118 2/20 0.40
CYP3A4 P08684 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4868729 0.86 MPL (0.58) MPLHSD17B10MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL4875400 0.85 MPL (0.57) MPLHSD17B10MAPTMEN1KMT2A
SCHEMBL474677 0.80 MPL (0.74) MPLHSD17B10MAPTMEN1KMT2A
SCHEMBL1801817 0.78 MPL (0.63) MPLHSD17B10MAPTMEN1KMT2A
SCHEMBL15417598 0.75 MPL (0.53) MPLHSD17B10MAPTMEN1KMT2A
SCHEMBL474161 0.75 MPL (1.00) MPLHSD17B10MAPTMEN1KMT2A
SCHEMBL27589579 0.73 HSD17B10 (0.59) MPLHSD17B10MAPTMEN1KMT2A
SCHEMBL44739 0.73 MPL (1.00) MPLHSD17B10MAPTMEN1KMT2A
SCHEMBL30122901 0.73 MPL (1.00) MPLHSD17B10MAPTMEN1KMT2A
SCHEMBL24107598 0.72 MEN1 (0.59) MPLHSD17B10MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9474758-B2 Thienopyrimidinedione derivatives as TRPA1 modulators GLENMARK PHARMACEUTICALS, S.A. (CH) 2016-10-25 US disclosed
US-20150150876-A1 THIENOPYRIMIDINEDIONE DERIVATIVES AS TRPA1 MODULATORS GLENMARK PHARMACEUTICALS, S.A. (CH) 2015-06-04 US disclosed
US-8623880-B2 Fused pyrimidine-dione derivatives as TRPA1 modulators GLENMARK PHARMACEUTICALS S.A. (CH) 2014-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150150876-A1 THIENOPYRIMIDINEDIONE DERIVATIVES AS TRPA1 MODULATORS TRPA1, TRPV1, TRPV6 MPL 2776/4885HSD17B10 2853/4885MAPT 2021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.